A translational model-based approach to inform the choice of the dose in phase 1 oncology trials: the case study of erdafitinib - Tosca, E. M.; Terranova, N.; Stuyckens, K.; Dosne, A. G.; Perera, T.; Vialard, J.; King, P.; Verhulst, T.; Perez-Ruixo, J. J.; Magni, P.; Poggesi, I. (Cancer Chemotherapy and Pharmacology, 2022)